← Leaderboards
Mark Y Chiang
University Of Pennsylvania
$6,282,744
Attributed
$6,282,744
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $935K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,282,744 · 4
By mechanism
R01$5,616,384 · 3
K08$666,360 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Warren S Pear$28,448,095
- Taku Kambayashi$10,768,805
- Robert H Vonderheide$28,425,019
- Andras Schaffer$703,252
- Bruce A Hug$648,135
Others in their field
Top investigators on “Leukemogenesis”
- Carlo M Croce · Thomas Jefferson University$15,546,518
- Kevin M Shannon · University Of California San Francisco$15,106,877
- Dong-Er Zhang · Beth Israel Deaconess Medical Center$14,880,271
- Charles G. Mullighan · St. Jude Children'S Research Hospital$14,309,762
- Pier Paolo Pandolfi · Sloan-Kettering Institute For Cancer Res$13,841,261
- Scott Hiebert · Vanderbilt University$13,163,996
Research focus
LeukemogenesisCellsComplexSignal TransductionNotch ProteinMalignant NeoplasmsNotch1 GeneAcute T Cell LeukemiaChromatinCombatLeukemiaClinical TrialsGenetic TranscriptionPathway InteractionsT-LymphocyteLearningMaintenanceTissuesInnovationTranscription FactorBindingOncogenicAdultOncogenes
Grant awards (18)
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL$453,685
R01 · FY2025 · CA · contact PI
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL$450,646
R01 · FY2024 · CA · contact PI
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development$493,556
R01 · FY2023 · AI · contact PI
ETS1-dependent combinatorial control of oncogenic transcription in Notch-activated T-ALL$441,405
R01 · FY2023 · CA · contact PI
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development$503,927
R01 · FY2022 · AI · contact PI
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development$508,593
R01 · FY2021 · AI · contact PI
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development$504,685
R01 · FY2020 · AI · contact PI
Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development$497,710
R01 · FY2019 · AI · contact PI
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia$343,925
R01 · FY2019 · CA · contact PI
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia$354,563
R01 · FY2018 · CA · contact PI
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia$354,563
R01 · FY2017 · CA · contact PI
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia$354,563
R01 · FY2016 · CA · contact PI
Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia$354,563
R01 · FY2015 · CA · contact PI
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia$133,272
K08 · FY2010 · CA · contact PI
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia$133,272
K08 · FY2009 · CA · contact PI
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia$133,272
K08 · FY2008 · CA · contact PI
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia$133,272
K08 · FY2007 · CA · contact PI
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia$133,272
K08 · FY2006 · CA · contact PI